¼¼°èÀÇ Àü¸³¼±¾Ï Áø´Ü¾à ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2033³â)
Global Prostate Cancer Diagnostics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
»óǰÄÚµå : 1676284
¸®¼­Ä¡»ç : Value Market Research
¹ßÇàÀÏ : 2025³â 03¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 150 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,920 £Ü 5,671,000
PDF & Excel (Single User License) help
PDF ¹× Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,730 £Ü 6,843,000
PDF & Excel (10-user License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 10¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,430 £Ü 10,750,000
PDF & Excel (Corporate User License) help
PDF ¹× Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy & Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â ÀüÀÚÆÄÀÏÀÇ ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ Àü¸³¼±¾Ï Áø´Ü¾à ½ÃÀå ±Ô¸ð´Â 2024³â 95¾ï 9,000¸¸ ´Þ·¯¿¡¼­ 2033³â±îÁö´Â 177¾ï ´Þ·¯·Î ¼ºÀåÇϸç, 2026-2033³âÀÇ ¿¹Ãø ±â°£ Áß 7.04%ÀÇ °ß°íÇÑ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Àü¸³¼±¾Ï Áø´Ü ½ÃÀåÀº Àü¸³¼±¾Ï ¹ßº´·ü Áõ°¡¿Í Á¶±â ¹ß°ßÀÇ Á߿伺¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó Å« ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. Àü ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿¡ µû¶ó Àü¸³¼±¾ÏÀÇ À¯º´·üÀº Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ´Â È¿°úÀûÀÎ Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ¸ÖƼÆÄ¶ó¹ÌÅÍ MRI, ÷´Ü ÃÊÀ½ÆÄ ±â¼ú µî ¿µ»ó ±â¼úÀÇ Çõ½ÅÀ¸·Î Àü¸³¼±¾ÏÀÇ °ËÃâ ¹× Æ¯¼ºÈ­ÀÇ Á¤È®µµ°¡ Çâ»óµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àü¸³¼±Æ¯ÀÌÇ׿ø(PSA) °Ë»ç ¹× À¯ÀüÀÚ ÇÁ·ÎÆÄÀϸµÀ» Æ÷ÇÔÇÑ ¹ÙÀÌ¿À¸¶Ä¿ ±â¹Ý °Ë»çÀÇ °³¹ßÀº Àü¸³¼±¾Ï °ü¸®¿¡ ´ëÇÑ °³º°È­µÈ Á¢±ÙÀ» °¡´ÉÇÏ°Ô ÇÏ´Â µî Áø´ÜÀÇ ÆÇµµ¸¦ ¹Ù²Ù°í ÀÖ½À´Ï´Ù.

±â¼úÀÇ ¹ßÀüÀº Àü¸³¼±¾Ï Áø´Ü ½ÃÀåÀÇ ¹Ì·¡¸¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù. ÀΰøÁö´É°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀ» ¿µ»ó Áø´Ü¿¡ ÅëÇÕÇÏ¿© Á¾¾ç ¹ß°ß°ú À§Çèµµ ºÐ·ùÀÇ Á¤È®µµ¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼úÀº ¹æ´ëÇÑ ¾çÀÇ µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© ±âÁ¸ ¹æ¹ýÀ¸·Î´Â ³õÄ¡±â ½¬¿î ÆÐÅϰú ÀÌ»óÀ» ½Äº°ÇÒ ¼ö ÀÖÀ¸¸ç, ±Ã±ØÀûÀ¸·Î º¸´Ù Á¤È®ÇÑ Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ ¾×ü»ý°Ë ±â¼úÀÇ ¹ßÀüÀº Áúº´ÀÇ ÁøÇà°ú Ä¡·á ¹ÝÀÀÀ» ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ´Â ºñħ½ÀÀû ´ë¾ÈÀ» Á¦°øÇÔÀ¸·Î½á ÀÓ»óÀǰ¡ Ȱ¿ëÇÒ ¼ö ÀÖ´Â Áø´Ü ´É·ÂÀ» ´õ¿í Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

¶ÇÇÑ Àü¸³¼±¾Ï Áø´Ü ½ÃÀåÀº Á¦¾à ¹× Áø´Ü ȸ»çµéÀÌ Àü¸³¼±¾ÏÀÇ ¹ß°ß ¹× °ü¸®¿¡ ´ëÇÑ ¹ÌÃæÁ· ¼ö¿ä¸¦ ÀνÄÇÔ¿¡ µû¶ó ¿¬±¸°³¹ß¿¡ ´ëÇÑ ÅõÀÚ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ÇýÅÃÀ» ¹ÞÀ» °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÓ»ó½ÃÇèÀ» ÁøÇàÇϰí Çõ½ÅÀûÀÎ Áø´Ü ¼Ö·ç¼ÇÀ» ½ÃÀå¿¡ Ãâ½ÃÇϱâ À§Çؼ­´Â Çаè, ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ ¹× ÀÌÇØ°ü°èÀÚµéÀÇ Çù·ÂÀÌ ÇʼöÀûÀÔ´Ï´Ù. ±ÔÁ¦ ´ç±¹ÀÌ ½Å±â¼úÀÇ ½ÂÀÎ ÀýÂ÷¸¦ °£¼ÒÈ­ÇÏ´Â °¡¿îµ¥, Áø´Ü ¾à¹°À» Á¾ÇÕÀûÀÎ Àü¸³¼±¾Ï Ä¡·á °æ·Î¿¡ ÅëÇÕÇÏ´Â ¹æÇâÀ¸·Î ÃÊÁ¡ÀÌ ¿Å°Ü°¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÇÕÀº ȯÀÚ °á°ú¸¦ ÃÖÀûÈ­Çϱâ À§ÇØ Ä¡·á °èȹ°ú Áø´ÜÀû ÀλçÀÌÆ®¸¦ °áÇÕÇÑ ´ÙÇÐÁ¦Àû Á¢±ÙÀÇ Á߿伺À» °­Á¶ÇÒ °ÍÀÔ´Ï´Ù. Àü¸³¼±¾Ï¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó °ËÁø ¹× ±³À°À» ÃËÁøÇϱâ À§ÇÑ °øÁߺ¸°Ç ³ë·ÂÀº ÷´Ü Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇÏ°í ±Ã±ØÀûÀ¸·Î ȯÀÚÀÇ »ýÁ¸À²°ú »îÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µ¥ ±â¿©ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

´ç»çÀÇ º¸°í¼­´Â °í°´¿¡°Ô ´Ù¾çÇÑ »ê¾÷ ¹× ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÌ°í ½Ç¿ëÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇϱâ À§ÇØ ¼¼½ÉÇÏ°Ô ÀÛ¼ºµÇ¾ú½À´Ï´Ù. °¢ º¸°í¼­¿¡´Â ½ÃÀå »óȲÀ» ¿ÏÀüÈ÷ ÀÌÇØÇϱâ À§ÇÑ ¸î °¡Áö Áß¿äÇÑ ¿ä¼Ò°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.

½ÃÀå °³¿ä : Á¤ÀÇ, ºÐ·ù, »ê¾÷ ÇöȲ µî ½ÃÀå¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ ¼Ò°³.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ : ½ÃÀå ¼ºÀå¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â ÁÖ¿ä ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ ¹× °úÁ¦¸¦ »ó¼¼ÇÏ°Ô ºÐ¼®ÇÕ´Ï´Ù. ÀÌ ¼½¼Ç¿¡¼­´Â ±â¼ú ¹ßÀü, ±ÔÁ¦ º¯È­, »õ·Î¿î µ¿Çâ µîÀÇ ¿äÀÎÀ» °ËÅäÇÕ´Ï´Ù.

¼¼ºÐÈ­ ºÐ¼® : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ª µîÀÇ ±âÁØ¿¡ µû¶ó ½ÃÀåÀ» ¸íÈ®ÇÑ ºÎ¹®À¸·Î ºÐ·ùÇÕ´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ °¢ ºÎ¹®ÀÇ ¼º°ú¿Í ÀáÀç·ÂÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

°æÀï ±¸µµ : ½ÃÀå Á¡À¯À², Á¦Ç° Æ÷Æ®Æú¸®¿À, Àü·«Àû ±¸»ó, À繫 ½ÇÀû µî ÁÖ¿ä ½ÃÀå ±â¾÷¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ Æò°¡¸¦ Á¦°øÇÕ´Ï´Ù. ÁÖ¿ä ±â¾÷ÀÌ Ã¤ÅÃÇϰí ÀÖ´Â °æÀï ¿ªÇÐ ¹× ÁÖ¿ä Àü·«¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¿¹Ãø : °ú°Å µ¥ÀÌÅÍ¿Í ÇöÀç ½ÃÀå »óȲÀ» ¹ÙÅÁÀ¸·Î ÀÏÁ¤ ±â°£ Áß ½ÃÀå ±Ô¸ð¿Í ¼ºÀå Ãß¼¼¸¦ ¿¹ÃøÇÕ´Ï´Ù. ¿©±â¿¡´Â Á¤·®Àû ºÐ¼®°ú ¹Ì·¡ ½ÃÀå ±ËÀûÀ» º¸¿©ÁÖ´Â ±×·¡ÇÁ Ç¥½Ã°¡ Æ÷ÇԵ˴ϴÙ.

Áö¿ª ºÐ¼® : Áö¿ªº° ½ÃÀå ¼º°ú¸¦ Æò°¡Çϰí ÁÖ¿ä ½ÃÀå ¹× Áö¿ª µ¿ÇâÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. Áö¿ª ½ÃÀå ¿ªÇÐ ¹× ºñÁî´Ï½º ±âȸ¸¦ ÀÌÇØÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

»õ·Î¿î µ¿Çâ°ú ±âȸ : ÇöÀç ½ÃÀå µ¿Çâ°ú »õ·Î¿î ½ÃÀå µ¿Çâ, ±â¼ú Çõ½Å, ÀáÀçÀû ÅõÀÚ ´ë»ó ºÐ¾ß¸¦ ÆÄ¾ÇÇÕ´Ï´Ù. ¹Ì·¡ ½ÃÀå °³¹ß ¹× ¼ºÀå Àü¸Á¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå °³¿ä

Á¦3Àå Àü¸³¼±¾Ï Áø´Ü¾à »ê¾÷ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦5Àå ¼¼°èÀÇ Àü¸³¼±¾Ï Áø´Ü¾à ½ÃÀå ºÐ¼® : °Ë»ç À¯Çüº°

Á¦6Àå ¼¼°èÀÇ Àü¸³¼±¾Ï Áø´Ü¾à ½ÃÀå ºÐ¼® : À¯Çüº°

Á¦7Àå ¼¼°èÀÇ Àü¸³¼±¾Ï Áø´Ü¾à ½ÃÀå ºÐ¼® : ÃÖÁ¾ ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ Àü¸³¼±¾Ï Áø´Ü¾à ½ÃÀå ºÐ¼® : Áö¿ªº°

Á¦9Àå Àü¸³¼±¾Ï Áø´Ü¾à ±â¾÷ÀÇ °æÀï ±¸µµ

Á¦10Àå ±â¾÷ °³¿ä

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Prostate Cancer Diagnostics Market size is anticipated to grow from USD 9.59 Billion in 2024 to USD 17.7 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.04% during the forecast period of 2026 to 2033.

The prostate cancer diagnostics market is poised for significant growth, driven by the increasing incidence of prostate cancer and the growing awareness of the importance of early detection. As the global population ages, the prevalence of prostate cancer is expected to rise, leading to a heightened demand for effective diagnostic tools. Innovations in imaging technologies, such as multiparametric MRI and advanced ultrasound techniques, are enhancing the accuracy of prostate cancer detection and characterization. Additionally, the development of biomarker-based tests, including prostate-specific antigen (PSA) testing and genetic profiling, is revolutionizing the diagnostic landscape, enabling personalized approaches to prostate cancer management.

Technological advancements are also shaping the future of the prostate cancer diagnostics market. The integration of artificial intelligence and machine learning algorithms into diagnostic imaging is improving the precision of tumor detection and risk stratification. These technologies can analyze vast amounts of data to identify patterns and anomalies that may be missed by traditional methods, ultimately leading to more accurate diagnoses. Furthermore, the rise of liquid biopsy techniques is providing a non-invasive alternative for monitoring disease progression and treatment response, further enhancing the diagnostic capabilities available to clinicians.

Moreover, the prostate cancer diagnostics market will benefit from increased investment in research and development, as pharmaceutical companies and diagnostic firms recognize the unmet needs in prostate cancer detection and management. Collaborative efforts between academic institutions, healthcare providers, and industry stakeholders will be crucial in advancing clinical trials and bringing innovative diagnostic solutions to market. As regulatory bodies continue to streamline approval processes for new technologies, the focus will shift towards integrating diagnostics into comprehensive prostate cancer care pathways. This integration will emphasize the importance of multidisciplinary approaches, combining diagnostic insights with treatment planning to optimize patient outcomes. As awareness of prostate cancer grows, public health initiatives aimed at promoting screening and education will further drive the demand for advanced diagnostic tools, ultimately contributing to improved survival rates and quality of life for patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Test Type

By Type

By End Use

TABLE OF CONTENTS

1. PREFACE

2. EXECUTIVE SUMMARY

3. PROSTATE CANCER DIAGNOSTICS INDUSTRY ANALYSIS

4. VALUE CHAIN ANALYSIS

5. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE

6. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY TYPE

7. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY END USE

8. GLOBAL PROSTATE CANCER DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

9. COMPETITIVE LANDSCAPE OF THE PROSTATE CANCER DIAGNOSTICS COMPANIES

10. COMPANY PROFILES OF PROSTATE CANCER DIAGNOSTICS INDUSTRY

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â